Target intelligence / Profile preview

Kelch-like protein 4 (KLHL4)

Target
KLHL4
Molecular classification
Cytoskeletal protein, Kelch-like family, BTB/POZ domain protein
01

Overview

Kelch-like protein 4 (KLHL4) is a cytoskeletal-associated protein encoded on the X chromosome, containing six Kelch repeats and a BTB/POZ domain, typical of its family[1][4][7]. These domains facilitate protein-protein interactions, including dimerization and adapter functions for ubiquitin ligases[3][4]. KLHL4 is expressed in several fetal tissues, including tongue and palate, and has been associated with congenital X-linked cleft palate (CPX)[4]. It mediates interactions with Cul3 E3 ligase and is shown to regulate cell-cycle progression by activating transcription of p21 through enhancement of p53 pathway activity[2][4]. Although the precise biological function is still under investigation, KLHL4 and its family members play roles in cytoskeletal organization, gene expression, and protein ubiquitination[3][7]. No drugs, biomarkers, or therapeutic safety data are currently associated with KLHL4, reflecting its status as a non-canonical drug target as of 2024[2][3][7].

Other names
KLHL4KIAA1687kelch-like family member 4KHL4DKELCHLkelch-like protein 4
02

Biological functions

Protein-protein interaction (via BTB/POZ domain; dimerization)Actin binding (putative, inferred from family traits)Transcriptional regulation (activates p21WAF/CDKN1A by facilitating p53 interaction)Involved in ubiquitination (binds Cul3 E3 ligase, potential substrate adapter for protein ubiquitination, and proteasomal degradation)
03

Disease associations

X-linked cleft palate (CPX)Possibly cancer (KLHL family involved in cancer, but KLHL4-specific roles in tumorigenesis are still emerging)

Beyond the preview

Go deeper on Kelch-like protein 4 (KLHL4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like protein 4 (KLHL4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call